Variant report
Variant | nsv966486 |
---|---|
Chromosome Location | chr4:172114410-172137862 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:172107312..172109351-chr4:172113285..172116114,4 | MCF-7 | breast: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-GALNTL6-4 | chr4:172136919-172136961 | l_2776_chr4:172136918-172152369_testes |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs554675554 | chr4:172123896-172123897 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs574464325 | chr4:172123963-172123964 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs77304849 | chr4:172123998-172123999 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs142415800 | chr4:172124012-172124013 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs189431350 | chr4:172124054-172124055 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs531974457 | chr4:172124071-172124072 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs75804374 | chr4:172124128-172124129 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs180900418 | chr4:172124165-172124166 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs185565177 | chr4:172124182-172124183 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs1388315 | chr4:172124189-172124190 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs11722373 | chr4:172124215-172124216 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs376385174 | chr4:172124216-172124217 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs535153073 | chr4:172124253-172124254 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs375601659 | chr4:172124280-172124281 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs568946436 | chr4:172124286-172124287 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs538087793 | chr4:172124323-172124324 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs557670097 | chr4:172124369-172124370 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs577968054 | chr4:172124381-172124382 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs11726684 | chr4:172124421-172124422 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs532554529 | chr4:172124426-172124427 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs35550005 | chr4:172124427-172124428 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs6836611 | chr4:172124465-172124466 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs190442296 | chr4:172124570-172124571 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs543135380 | chr4:172124572-172124573 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs563046015 | chr4:172124587-172124588 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs151288334 | chr4:172124617-172124618 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs560887273 | chr4:172124633-172124634 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs529740787 | chr4:172124657-172124658 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs545544637 | chr4:172124662-172124663 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs141658323 | chr4:172124721-172124722 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs527954181 | chr4:172124722-172124723 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs147060198 | chr4:172124741-172124742 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs373349836 | chr4:172124744-172124745 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs376905754 | chr4:172124748-172124749 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs6841957 | chr4:172124768-172124769 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
36 | rs568887486 | chr4:172124798-172124799 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs531315605 | chr4:172124804-172124805 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs7663283 | chr4:172124830-172124831 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs571487743 | chr4:172124895-172124896 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs573184390 | chr4:172124939-172124940 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs532229637 | chr4:172124943-172124944 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs113030398 | chr4:172124954-172124955 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs552498813 | chr4:172124956-172124957 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs371830257 | chr4:172124966-172124967 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs554148516 | chr4:172125017-172125018 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs554149843 | chr4:172125058-172125059 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs142339396 | chr4:172125078-172125079 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs181981942 | chr4:172125083-172125084 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs556294895 | chr4:172125093-172125094 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs576450181 | chr4:172125095-172125096 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 16272173 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Breast cancer | 21785460 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21633010 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20581869 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Neuroblastoma | 16790693 | CNVD |
Developmental delay | 22127048 | CNVD |
Schizophrenia | 23813976 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:172123800-172124400 | Enhancers | Pancreas | Pancrea |
2 | chr4:172123800-172124400 | Enhancers | A549 | lung |
3 | chr4:172124400-172125400 | Weak transcription | A549 | lung |
4 | chr4:172124600-172125000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
5 | chr4:172124600-172125000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr4:172124800-172125400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
7 | chr4:172125400-172125600 | Enhancers | A549 | lung |